MicroRNAs in Mental Health: From Biological Underpinnings to Potential Therapies
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Psychiatric illnesses are disabling disorders with poorly understood underlying pathophysiologies. However, it is becoming increasingly evident that these illnesses result from disruptions across whole cellular networks rather than any particular monoamine system. Recent evidence continues to support the hypothesis that these illnesses arise from impairments in cellular plasticity cascades, which lead to aberrant information processing in the circuits that regulate mood, cognition, and neurovegetative functions (sleep, appetite, energy, etc.). As a result, many have begun to consider future therapies that would be capable of affecting global changes in cellular plasticity to restore appropriate synaptic function and neuronal connectivity. MicroRNAs (miRNAs) are non-coding RNAs that can repress the gene translation of hundreds of their targets and are therefore well-positioned to target a multitude of cellular mechanisms. Here, we review some properties of miRNAs and show they are altered by stress, glucocorticoids, mood stabilizers, and in a particular psychiatric disorder, schizophrenia. While this field is still in its infancy, we consider their potential for regulating behavioral phenotypes and targeting key predicted signaling cascades that are implicated in psychiatric illness. Clearly, considerable research is required to better determine any therapeutic potential of targeting miRNAs; however, these agents may provide the next generation of effective therapies for psychiatric illnesses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Chronic psychosocial stress is known to have adverse physiological effects that contribute to cardiovascular disease, impaired immune function, inflammatory diseases, and impaired neural function and behavior (Grippo and Johnson 2009; Sapolsky et al. 2000).”
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & Meaney, M. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2270 · Cited by 3,531
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · cited 1×
“…with psychiatric disorders have identified ventricular alterations and volumetric changes in regulatory regions such as the limbic system and prefrontal cortex, which are thought to be vital to proper mood regulation (Drevets 2000; Drevets et al. 1997, 1998, 2008; Neumeister et al. 2005).”
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · cited 1×
“…several emerging themes associated with the biological underpinnings of psychiatric illnesses, including fundamental impairments in neuroplasticity (Pittenger and Duman 2008), increased neuronal vulnerability to aberrant stimuli (Kato 2008), and dysregulation in neurotrophic factor signaling…”
Diorio, D., Viau, V, & Meaney, M. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-09-03839.1993 · Cited by 1,151
The subgenual anterior cingulate cortex in mood disorders
Drevets, W. C., Savitz, J., & Trimble, M. (2008) · CNS Spectrums · doi:10.1017/s1092852900013754 · Cited by 1,109
Involvement of a calcineurin/ inhibitor-1 phosphatase cascade in hippocampal long-term depression
Mulkey, R. M., Endo, S., Shenolikar, S., & Malenka, R. C. (1994) · Nature · doi:10.1038/369486a0 · Cited by 1,083 · cited 1×
“Interestingly, there is much support in the literature for calcineurin’s role in neuroplasticity (Malleret et al. 2001; Mulkey et al. 1994; Wang and Kelly 1997; Winder et al. 1998).”
Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression
Drevets, W. C. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26027-5 · Cited by 659 · cited 1×
“…with psychiatric disorders have identified ventricular alterations and volumetric changes in regulatory regions such as the limbic system and prefrontal cortex, which are thought to be vital to proper mood regulation (Drevets 2000; Drevets et al. 1997, 1998, 2008; Neumeister et al. 2005).”
Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model
Stark, K. L., Xu, B., Bagchi, A., Lai, W.-S., Liu, H., Hsu, R., Wan, X., Pavlidis, P., Mills, A. A., Karayiorgou, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.138 · Cited by 648 · cited 1×
“2 microdeletion, researchers found biogenic changes in brain miRNAs influenced by this microdeletion (Stark et al. 2008).”
Wellman, C. L. (2001) · Journal of Neurobiology · doi:10.1002/neu.1079 · Cited by 594 · cited 2×
“…to modify dendritic pyramidal cells and suppress gliogenesis in the prefrontal cortex (Cerqueira et al. 2005; Czeh et al. 2008; Diorio et al. 1993; Wellman 2001), impair LTP and inhibit neurogenesis in the hippocampus, and increase synaptic excitability as well as lead to neuronal hippocampal…”
Perkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J., & Hammond, S. M. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r27 · Cited by 574 · cited 1×
“They found that 16 miRNAs were significantly regulated in the prefrontal cortex of schizophrenic patients (15 downregulated, 1 upregulated) compared to healthy controls (Perkins et al. 2007).”
Role of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders
Duman, R. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:011 · Cited by 537
Malleret, G., Haditsch, U., Genoux, D., Jones, M. W., Bliss, T. V. P., Vanhoose, A. M., Weitlauf, C., Kandel, E. R., Winder, D. G., & Mansuy, I. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00264-1 · Cited by 470 · cited 1×
“Interestingly, there is much support in the literature for calcineurin’s role in neuroplasticity (Malleret et al. 2001; Mulkey et al. 1994; Wang and Kelly 1997; Winder et al. 1998).”
MicroRNA regulation of DNA repair gene expression in hypoxic stress
Crosby, M. E., Kulshreshtha, R., Ivan, M., & Glazer, P. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2516 · Cited by 437 · cited 2×
“In particular, miRNAs have been implicated in the way cells respond to oxidative stress (Leung et al. 2006; Marsit et al. 2006), nutrient deprivation (Bhattacharyya et al. 2006), and DNA damage (Crosby et al. 2009; Pulkkinen et al. 2008).”
Toward constructing an endophenotype strategy for bipolar disorders
Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.006 · Cited by 423
Self-citationEpigenetic programming of stress responses through variations in maternal care
FISH, E. W., SHAHROKH, D., BAGOT, R., CALDJI, C., BREDY, T., SZYF, M., & MEANEY, M. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1330.011 · Cited by 361
Drevets, W. C., Öngür, D., & Price, J. L. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000370 · Cited by 352
Tabarés-Seisdedos, R., & Rubenstein, J. L. R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.2 · Cited by 244 · cited 6×
“…of genes that could potentially be involved in many Table 1 continued miRNA Fold change Chromosome location(s) Study Brain region miR-124-1 NA 8p Tabares-Seisdedos and Rubenstein (2009) NA miR-598 NA 8p Tabares-Seisdedos and Rubenstein (2009) NA miR-383 NA 8p Tabares-Seisdedos and Rubenstein…”
InfluentialUchida, S., Nishida, A., Hara, K., Kamemoto, T., Suetsugi, M., Fujimoto, M., Watanuki, T., Wakabayashi, Y., Otsuki, K., McEwen, B. S., et al. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06218.x · Cited by 203 · cited 1×
“Another recent study found that miR-18a downregulated glucocorticoid receptor (GR) protein in the paraventricular nucleus (PVN) in Fischer 344 (F344) but not Sprague– Dawley (SD) rats undergoing repeated restraint stress (Uchida et al. 2008).”
Establishing an Agenda for Translational Research on PTSD
MILLER, M. M., & McEWEN, B. S. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.023 · Cited by 101
Cited by
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease
Ha, T.-Y. (2011) · Immune Network · doi:10.4110/in.2011.11.3.135 · Cited by 365
Smalheiser, N. R., Lugli, G., Rizavi, H. S., Torvik, V. I., Turecki, G., & Dwivedi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033201 · Cited by 324
Wei, Z.-X., Xie, G.-J., Mao, X., Zou, X.-P., Liao, Y.-J., Liu, Q.-S., Wang, H., & Cheng, Y. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0622-2 · Cited by 227
“Even though the cellular and molecular basis of neuropsychiatric diseases are still far from being understood, it is considered that cellular network disruption and aberrant information processing in the neural circuits play crucial roles in disease development [8].”
BackgroundLopez, J. P., Kos, A., & Turecki, G. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000379 · Cited by 108
Metadata
- Authors
- Hunsberger, J. G., Austin, D. R., Chen, G., & Manji, H. K.
- Venue
- NeuroMolecular Medicine
- Published
- 2009-06-20
- Volume
- 11
- Issue
- 3
- Pages
- 173-182
- ISSN
- 1535-1084 (ISSN-L)
- 1559-1174
- OpenAlex
- W2057460717
- Cited by
- 98
- References
- 21
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.